These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases. Hurley MJ; Deacon RMJ; Beyer K; Ioannou E; Ibáñez A; Teeling JL; Cogram P Pharmacol Ther; 2018 Aug; 188():36-44. PubMed ID: 29514054 [TBL] [Abstract][Full Text] [Related]
6. Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer's disease. Tan Z; Garduño BM; Aburto PF; Chen L; Ha N; Cogram P; Holmes TC; Xu X Acta Neuropathol Commun; 2022 Dec; 10(1):182. PubMed ID: 36529803 [TBL] [Abstract][Full Text] [Related]
8. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor. Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793 [TBL] [Abstract][Full Text] [Related]
11. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674 [TBL] [Abstract][Full Text] [Related]
12. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Liu HL; Zhao G; Zhang H; Shi LD Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591 [TBL] [Abstract][Full Text] [Related]
13. First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging. Cogram P; Garduño BM; Ren B; Xu X J Alzheimers Dis; 2024; 98(1):333-336. PubMed ID: 38393919 [TBL] [Abstract][Full Text] [Related]
14. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
15. Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease. Ardiles AO; Tapia-Rojas CC; Mandal M; Alexandre F; Kirkwood A; Inestrosa NC; Palacios AG Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13835-40. PubMed ID: 22869717 [TBL] [Abstract][Full Text] [Related]
16. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
17. Rodent models for Alzheimer's disease drug discovery. Puzzo D; Gulisano W; Palmeri A; Arancio O Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: transgenic models to test new chemicals and pharmaceuticals. Miller CC; Anderton BH Curr Opin Biotechnol; 1992 Dec; 3(6):683-6. PubMed ID: 1369125 [TBL] [Abstract][Full Text] [Related]
19. Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of Alzheimer's Disease. Inestrosa NC; Ríos JA; Cisternas P; Tapia-Rojas C; Rivera DS; Braidy N; Zolezzi JM; Godoy JA; Carvajal FJ; Ardiles AO; Bozinovic F; Palacios AG; Sachdev PS Brain Pathol; 2015 Nov; 25(6):679-91. PubMed ID: 25351914 [TBL] [Abstract][Full Text] [Related]
20. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP? Howlett DR; Richardson JC Histol Histopathol; 2009 Jan; 24(1):83-100. PubMed ID: 19012248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]